The tumor data in host mice with deletion of Tyk2 in specific immune subsets showed that TYK2 signaling in T cells, NK cells, macrophages, neutrophils or Kupffer cells is not required for immunosurveillance of CRLM. Here, TYK2 is linked to neoplasm.